Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665255 | SCV000789346 | uncertain significance | Pyruvate dehydrogenase E3 deficiency | 2017-02-07 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000665255 | SCV002519490 | pathogenic | Pyruvate dehydrogenase E3 deficiency | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000665255 | SCV003440154 | uncertain significance | Pyruvate dehydrogenase E3 deficiency | 2022-07-31 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 480 of the DLD protein (p.Ile480Met). This variant is present in population databases (rs772512477, gnomAD 0.006%). This missense change has been observed in individual(s) with dihydrolipoamide dehydroganse deficiency (PMID: 20652410). ClinVar contains an entry for this variant (Variation ID: 550498). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |